Skip to main content
. 2022 Sep 12;2022:3796783. doi: 10.1155/2022/3796783

Table 2.

Response to treatment with trifluridine/tipiracil (FTD/TPI); n = 107.

Response to FTD/TPI treatment Number (%)
Patients not evaluated 7 (7)
Complete response (CR) 1 (1)
Partial response (PR) 3 (3)
Stable disease (SD) 28 (28)
Progressive disease (PD) 68 (68)